Home›Companies›Biotech & Pharma›Gliknik

Gliknik Inc

Develops biologic drugs for people with cancer and immune disorders.

Updated Nov 9, 2026·Latest SEC filing Sep 17, 2026·Suggest an edit

About Gliknik

Gliknik is a private company based in Baltimore, Maryland. It has reported $54,672,737 raised in ten offerings on Form D since September 2009. Its chief executive is David Block.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 15, 2025Aug 21, 2025amended Sep 17, 2026$15,000,000fully sold11$1.3MDebt, Options, Securities on exerciseRule 506(b)Form D/A ↗1 earlier filing
Nov 6, 2024Nov 21, 2024amended Jan 24, 2025$5,286,743of $6.0M target25$211KDebt, Options, Securities on exerciseRule 506(b)Form D/A ↗1 earlier filing
Jun 29, 2023Jul 7, 2023amended Mar 21, 2024$9,175,302of $16.2M target23$398KEquity, Debt, OptionsRule 506(b)Form D/A ↗1 earlier filing
May 20, 2021Jun 2, 2021$4,300,005of $12.0M target4$1.0MEquityRule 506(b)Form D ↗
Sep 3, 2013Sep 12, 2013$2,835,000of $5.0M target13$218KEquity06Form D ↗
Aug 13, 2012Aug 27, 2012amended Apr 30, 2013$9,900,015of $15.0M target27$366KEquity06Form D/A ↗2 earlier filings
Aug 24, 2011Sep 6, 2011$2,038,552of $2.3M target21$97,074Equity06Form D ↗
Dec 21, 2010Jan 4, 2011$849,605of $3.9M target6$141KEquity, Options, Securities on exercise06Form D ↗
Aug 17, 2010Aug 30, 2010amended Sep 3, 2010$2,400,000of $4.0M target15$160KEquity, Options, Securities on exercise06Form D/A ↗1 earlier filing
Aug 19, 2008Sep 1, 2009amended Jan 13, 2010$2,887,515of $3.6M target23$125KEquity, Options, Securities on exercise06Form D/A ↗1 earlier filing
Total, ten offerings$54,672,737

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Gliknik's Form D filed Sep 17, 2026.

PF
CP
RS
Raymond Schinazi
Board Member
DB
David Broser
Director
EB
Elizabeth Block
Executive officer
DB
David Block
Co-Founder & CEO, director

Earlier filings also listed Paul Friedman (director, last listed Jan 2025), Scott Strome (director, last listed Mar 2024), Mark Lerner (director, last listed Mar 2024), Raymond Shinazi (director, last listed Jun 2021), Joseph Klein, III (director, last listed Jun 2021) and Geeta Vemuri (director, last listed Sep 2013).

Sources

  1. SECGliknik Inc Form D, filed Aug 21, 2025
  2. SECGliknik Inc Form D, filed Nov 21, 2024
  3. SECGliknik Inc Form D, filed Jul 7, 2023
  4. SECGliknik Inc Form D/A, filed Apr 26, 2013
  5. SECGliknik Inc Form D, filed Aug 27, 2012
  6. SECGliknik Inc Form D, filed Aug 30, 2010
  7. SECGliknik Inc Form D/A, filed Sep 1, 2009
  8. SECGliknik Inc filing history
  9. CompanyContact Gliknik
  10. CompanyGliknik terms of use
  11. CompanyGliknik Series C announcement